Hong Kong Advances Health Innovation with New Regulatory Framework and International Clinical Trial Initiatives

Secretary for Health chairs second meeting of Steering Committee on Health and Medical Innovation Development

The Secretary for Health, Professor Lo Chung-mau, chaired the second meeting of the Steering Committee on Health and Medical Innovation Development today (January 20) to discuss the development direction and policy initiatives for driving medical innovation in Hong Kong. Members also offered advice on the progress of establishing the Hong Kong Centre for Medical Products Regulation (CMPR) and the development of the Greater Bay Area International Clinical Trial Institute (GBAICTI).

​

At the meeting, members were briefed on the latest developments of establishing the CMPR. Since its establishment in June last year, the Preparatory Office for the CMPR has been taking forward a number of measures, including reviewing the regulatory work of drugs and medical devices in other regions to formulate a regulatory framework of drugs and medical devices suitable for Hong Kong, assessing the need for legislation, devising the restructuring of the existing regulatory functions and service plans for drugs and medical devices, and proposing the timetable for the establishment of the CMPR and the roadmap towards the adoption of "primary evaluation" in the first half of this year.

Furthermore, members also offered advice on the strategic development plan for the GBAICTI. The GBAICTI will take forward a number of key tasks this year, including promoting process optimisation, establishing a one-stop Hong Kong Clinical Trial Digital Portal, strengthening collaboration within the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), and planning for the GBAICTI's move into one of the wet laboratory-enabled buildings at the soon-to-be-completed Hong Kong-Shenzhen Innovation and Technology Park, with a view to further enhancing Hong Kong's overall clinical trial efficiency and capability.

Other key areas of work of the GBAICTI include talent training, strengthening Hong Kong's role in regional and international clinical trial networks, and establishing a high-level international clinical trial services platform in collaboration with other GBA cities, with a view to pushing ahead with the development of an advanced biomedical industry at full steam by capitalising on Hong Kong's unique advantages of enjoying strong support of the motherland and being closely connected to the world, thereby complementing the development goals as set out in the Development Plan for Shenzhen Park of Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone promulgated by the State Council.

Professor Lo said, "At today's meeting, members of the Steering Committee recognised the efforts of the Hong Kong Special Administrative Region (HKSAR) Government in promoting health and medical innovation and offered professional advice on the way forward regarding the development direction and policy initiatives. The Health Bureau (HHB) will actively follow up, and make every effort to take forward and implement the measures on expediting the reform of the approval mechanism for drugs and medical devices and enhancing Hong Kong's clinical trial capability on all fronts as set out in 'The Chief Executive’s 2024 Policy Address' by complementing technological innovation with institutional innovation. The HHB will also collaborate with Shenzhen to establish the GBA Clinical Trial Collaboration Platform to extend the research and development (R&D) network and expedite clinical trials; and establish the Real-World Study and Application Centre to leverage Hong Kong's vast and standardised high-quality medical databases, with a view to accelerating Hong Kong's development into an international health and medical innovation hub."

"In the Resolution of the Communist Party of China (CPC) Central Committee on Further Deepening Reform Comprehensively to Advance Chinese Modernization adopted by the Third Plenary Session of the 20th CPC Central Committee, it mentions the development strategy for further reforming the medical and healthcare systems and improving the mechanisms for supporting the development of innovative drugs and medical equipment. The HHB will embrace changes while staying principled, and leverage Hong Kong's advantages of 'one country, two systems', its high-quality healthcare professions and high compatibility with international standards and more, to develop Hong Kong into an international health and medical innovation hub and foster co-ordinated development with other GBA cities, so that patients may benefit from the most advanced diagnostic and treatment technologies, thereby achieving the goal of bringing the benefits of good drugs and R&D to Hong Kong. At the same time, we will promote the development of advanced biomedical technology industries and actively integrate into the overall national development by showing support for fostering new quality productive forces in biomedical technology as set out in the Resolution and the Development Plan to align with national development strategies," he emphasised.

Established and wholly owned by the HKSAR Government, the GBAICTI officially opened on November 21 last year in the Hong Kong Park of the Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone. The GBAICTI co-ordinates clinical trial resources in the public and private sectors in Hong Kong and serve as a one-stop clinical trial support platform for medical research institutions. The Greater Bay Area International Clinical Trials Center in the Shenzhen Park also officially opened on the same day. The "one institute, one center" will jointly establish the GBA Clinical Trial Collaboration Platform under the "one zone, two parks" co-ordinated development model.

Secretary for Health chairs second meeting of Steering Committee on Health and Medical Innovation Development Source: HKSAR Government Press Releases

Secretary for Health chairs second meeting of Steering Committee on Health and Medical Innovation Development Source: HKSAR Government Press Releases

DH reminds public to take precautions against heat-related illnesses during very hot weather

The Centre for Health Protection (CHP) of the Department of Health (DH) today (May 28) reminded members of the public to take appropriate precautions against heat-related illnesses, such as heat cramps, heat exhaustion and heat stroke, during very hot weather.

In a high-temperature environment, excessive sweating and difficulty in heat dissipation can cause stress to the body. Members of the public should take the following precautions:

Hydrate in a timely manner to prevent dehydration;

Wear light-coloured, loose-fitting and breathable clothing to minimise heat absorption and facilitate perspiration and heat dissipation;

Keep indoor areas well ventilated and maintain appropriate temperature and humidity, e.g. by opening windows or using a fan or air-conditioning;

Avoid strenuous exercise and prolonged activities such as hiking or trekking;

Arrange outdoor activities in the morning or the late afternoon, if possible, and bring enough water; and

Avoid beverages containing caffeine, such as coffee and tea, as well as alcoholic beverages, which may speed up water loss through the urinary system.

In addition, infants and children, the elderly, pregnant women, individuals with chronic illnesses such as heart disease or high blood pressure, overweight people and outdoor/manual workers are more susceptible to heat stroke. These groups should pay special attention to the following:

Infants and young children: Avoid going outside when the temperature is high. If they must go outside, adults should ensure they stay in places with moderate temperatures and good ventilation or air-conditioning. Infants and young children should never be left unattended in a confined space such as a vehicle;

The elderly, pregnant women, individuals with chronic illnesses and overweight people: Pay close attention to health conditions and seek help as soon as possible if experiencing any abnormalities in health indicators such as blood pressure, heart rate, etc or if there are fluctuations in health conditions. Avoid going out when the temperature is high. Make sure there is good ventilation, or turn on a fan or air-conditioner to keep an appropriate temperature indoors. High temperatures can also worsen the condition of people with chronic illnesses (such as cardiovascular and respiratory diseases). Therefore, they should have an ample supply of their usual medication and keep in contact with family members, neighbours and the community. People should seek immediate help if they feel unwell.

Outdoor/manual workers: Reschedule work to cooler hours as far as feasible. If working in a hot environment is unavoidable, provide shade where practicable and use ventilation and heat dissipation equipment. Once work has begun, gradually adjust the pace of work and take breaks in the shade to regain strength.

The DH reminded the public that heat stroke is one of the most common health risks in hot weather. Over the past five years, there have been over 200 hospital admissions due to heat stroke each year in Hong Kong, with two to five fatal cases occurring mainly during the summer months from May to September. Vulnerable groups are more susceptible to heat stroke. Symptoms include dizziness, headache, nausea, shortness of breath or confusion. In severe cases, patients may suffer from convulsions or become unconscious, which can be life-threatening if they are not cooled down and resuscitated in a timely manner.

Members of the public are also advised to pay attention to the latest weather, as well as the real-time and forecasted ultraviolet (UV) index released by the Hong Kong Observatory (HKO). When the UV index is high (6 or above), the public should note the following:

Avoid direct sunlight exposure to the skin and the eyes;

Apply broad-spectrum, water-resistant sunscreen liberally, with a sun protection factor (SPF) of at least 30 or higher, when participating in outdoor activities. Reapply every two hours if staying outdoors for long periods, or after swimming, sweating or towelling off;

While using DEET-containing insect repellents for personal protection against mosquito-borne diseases, apply sunscreen before insect repellent;

Seek shade;

Wear UV-blocking sunglasses;

Wear loose-fitting clothing with long-sleeves; and

Wear a wide-brimmed hat or use an umbrella.

If symptoms develop, such as dizziness, headache, nausea, shortness of breath or confusion, rest and seek help immediately, and seek medical advice as soon as possible.

For more health information, the public may visit theCHP's heat strokepage andUV radiation page; the HKO's Dial-a-Weather (1878 200),latestweather report and forecast,UV Indexand weather information forhiking and mountaineering; andpress releasesof the Labour Departmenton precautions against heat stroke for outdoor workers and their employers when the Heat Stress at Work Warning is in force.

Source: AI-found images